Cargando…

Laboratory surrogate markers of residual HIV replication among distinct groups of individuals under antiretroviral therapy

BACKGROUND: Residual HIV-1 replication among individuals under antiretroviral therapy (ART) relates to HIV micro-inflammation. OBJECTIVES: To determine the levels of residual HIV replication markers among distinct subgroups of antiretroviral-treated individuals. METHODS: One hundred sixteen patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giron, Leila Bertoni, Tenore, Simone B., Janini, Luis Mario Ramos, Sucupira, Maria Cecilia Araripe, Diaz, Ricardo Sobhie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6576780/ https://www.ncbi.nlm.nih.gov/pubmed/31206536 http://dx.doi.org/10.1371/journal.pone.0217502

Ejemplares similares

High prevalence and incidence of HIV-1 in a counseling and testing center in the city of Itajaí, Brazil
por: Grinberg, Gorki, et al.
Publicado: (2015)

Analysis of HIV-1 Protease Gene Reveals Frequent Multiple Infections Followed by Recombination among Drug Treated Individuals Living in São Paulo and Santos, Brazil
por: Nunes, Edsel Renata De Morais, et al.
Publicado: (2014)

Plasma Metabolomics Biosignature According to HIV Stage of Infection, Pace of Disease Progression, Viremia Level and Immunological Response to Treatment
por: Scarpelini, Bruno, et al.
Publicado: (2016)

Correction: Plasma Metabolomics Biosignature According to HIV Stage of Infection, Pace of Disease Progression, Viremia Level and Immunological Response to Treatment
por: Scarpellini, Bruno, et al.
Publicado: (2017)

Fitness Cost of Antiretroviral Drug Resistance Mutations on the pol Gene during Analytical Antiretroviral Treatment Interruption among Individuals Experiencing Virological Failure
por: Hunter, James R., et al.
Publicado: (2021)

Uniquely altered transcripts are associated with immune preservation in HIV infection
por: Zanoni, Michelle, et al.
Publicado: (2017)

Antiretroviral Drug-Resistance Mutations on the Gag Gene: Mutation Dynamics during Analytic Treatment Interruption among Individuals Experiencing Virologic Failure
por: Hunter, James R., et al.
Publicado: (2022)

The Virological and Immunological Characteristics of the HIV-1-Infected Population in Brazil: From Initial Diagnosis to Impact of Antiretroviral Use
por: Diaz, Ricardo Sobhie, et al.
Publicado: (2015)

Nicotinamide activates latent HIV-1 ex vivo in ART suppressed individuals, revealing higher potency than the association of two methyltransferase inhibitors, chaetocin and BIX01294
por: Samer, Sadia, et al.
Publicado: (2020)

Faster HIV-1 Disease Progression among Brazilian Individuals Recently Infected with CXCR4-Utilizing Strains
por: Sucupira, Maria Cecilia Araripe, et al.
Publicado: (2012)

HCV genotype profile in Brazil of mono-infected and HIV co-infected individuals: A survey representative of an entire country
por: Nutini, Mariana Fernanda Rodrigues, et al.
Publicado: (2020)

Thalidomide is Associated With Increased T Cell Activation and Inflammation in Antiretroviral-naive HIV-infected Individuals in a Randomised Clinical Trial of Efficacy and Safety
por: Vergara, Tânia R.C., et al.
Publicado: (2017)

Analysis of protease treatment-associated mutations in a group of HIV-1 subtype F infected individuals with two sequences obtained in different time points
por: Oliveros, Márcia Perez Resende, et al.
Publicado: (2010)

Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial
por: de Almeida Baptista, Marcella Vassão, et al.
Publicado: (2022)

Epigenetic Modulations in Activated Cells Early after HIV-1 Infection and Their Possible Functional Consequences
por: Maricato, Juliana T., et al.
Publicado: (2015)

Latency-associated DNA methylation patterns among HIV-1 infected individuals with distinct disease progression courses or antiretroviral virologic response
por: Mantovani, Nathalia, et al.
Publicado: (2021)

Could well-established, widely available, and simple laboratory techniques explain a laboratory origin of SARS-CoV-2?
por: Lloyd Jr, Robert M., et al.
Publicado: (2023)

Correction: Analysis of the Origin and Evolutionary History of HIV-1 CRF28_BF and CRF29_BF Reveals a Decreasing Prevalence in the AIDS Epidemic of Brazil
por: Ristic, Natalia, et al.
Publicado: (2011)

Analysis of the Origin and Evolutionary History of HIV-1 CRF28_BF and CRF29_BF Reveals a Decreasing Prevalence in the AIDS Epidemic of Brazil
por: Ristic, Natalia, et al.
Publicado: (2011)

Prevalence of transmitted HIV-1 antiretroviral resistance among patients initiating antiretroviral therapy in Brazil: a surveillance study using dried blood spots
por: de Moraes Soares, Celina M P, et al.
Publicado: (2014)

Replicate Aptima Assay for Quantifying Residual Plasma Viremia in Individuals on Antiretroviral Therapy
por: Bakkour, Sonia, et al.
Publicado: (2020)

Photoimmunotherapy Using Cationic and Anionic Photosensitizer-Antibody Conjugates against HIV Env-Expressing Cells
por: Sadraeian, Mohammad, et al.
Publicado: (2020)

Photoinduced Photosensitizer–Antibody Conjugates Kill HIV Env-Expressing Cells, Also Inactivating HIV
por: Sadraeian, Mohammad, et al.
Publicado: (2021)

Prevalence, Incidence Density, and Genotype Distribution of GB Virus C Infection in a Cohort of Recently HIV-1-Infected Subjects in Sao Paulo, Brazil
por: Giret, Maria Teresa M., et al.
Publicado: (2011)

Dolutegravir-associated resistance mutations after first-line treatment failure in Brazil
por: Diaz, Ricardo Sobhie, et al.
Publicado: (2023)

Transport of Explosive Residue Surrogates in Saturated Porous Media
por: Lavoie, Beth, et al.
Publicado: (2011)

High HPgV replication is associated with improved surrogate markers of HIV progression
por: Horemheb-Rubio, Gibran, et al.
Publicado: (2017)

Codon pairs of the HIV-1 vif gene correlate with CD4+ T cell count
por: Bizinoto, Maria Clara, et al.
Publicado: (2013)

Measurable Residual Disease (MRD) as a Surrogate Efficacy-Response Biomarker in AML
por: Meddi, Elisa, et al.
Publicado: (2023)

Modest deviations from optimal adherence to antiretroviral therapy promote residual HIV-1 replication in the absence of virological rebound in plasma
por: Pasternak, Alexander O, et al.
Publicado: (2011)

The COVID-19 second wave: A perspective to be explored
por: Diaz, Ricardo Sobhie, et al.
Publicado: (2020)

Hepatitis B virus variants in an HIV-HBV co-infected patient at different periods of antiretroviral treatment with and without lamivudine
por: Santos, Eneida A, et al.
Publicado: (2004)

Surrogate indicators of sensitivity in gynecologic cytology: Can they be used to improve the measurement of sensitivity in the laboratory?
por: Renshaw, Andrew A, et al.
Publicado: (2009)

Persistent HIV-1 replication during antiretroviral therapy
por: Martinez-Picado, Javier, et al.
Publicado: (2016)

Residual disease and immune infiltration as a new surrogate endpoint for TNBC post neoadjuvant chemotherapy
por: Luen, Stephen L., et al.
Publicado: (2019)

Surrogates are just surrogates, but helpful just the same
por: Fabian, Carol
Publicado: (2007)

Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple Sclerosis
por: Matthews, Lucy, et al.
Publicado: (2015)

A Laboratory Investigation of the Suspension, Transport, and Settling of Silver Carp Eggs Using Synthetic Surrogates
por: Garcia, Tatiana, et al.
Publicado: (2015)

Validation of Minimal Residual Disease as Surrogate Endpoint for Event-Free Survival in Childhood Acute Lymphoblastic Leukemia
por: Galimberti, Stefania, et al.
Publicado: (2018)

HIV replication and evolution in patients on highly active antiretroviral therapy
por: Siliciano, Robert F
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_9abi5oo13gmuovccfojt00fgna